Abrocitinib treatment in adolescents and adults with moderate-to-severe atopic dermatitis: Early pruritus responses from phase 3 trials jade mono-1 and jade mono-2

SESSION 1 / New systemic treatments
Jonathan SILVERBERG (Chicago, USA)


Overview

  1. Presentation
  2. Full version download as PDF
  3. Ask questions to the author

Authors retain copyright.



Ask questions to Jonathan SILVERBERG:

[contact-form-7 id=”3756″ title=”Ask question LIVE”]


Conflict of interest :